您要查找的是不是：
- Keywords glucagon like peptide 1;GLP 1 immunoreactive;non insulin dependent debates mellitus; 类胰升血糖肽-1;GLP-1免疫反应活性;非胰岛依赖型糖尿病;
- glucagon like peptide 胰升糖素样肽
- The gene is called GRPR for gastrin-releasing peptide receptor. 这个基因被称为GRPR，是释放胃泌激素缩氨酸受体的简称。
- The gene is called GRPR, for gastrin-releasing peptide receptor. 这种基因被称作GRPR，也就是胃泌素受体基因。
- The gene is called GRPR for dextrin (gastrin) releasing peptide receptor. 这种基因称之为GRPR-胃泌素释放肽受体。
- Glucagons like peptide - 1 胰升血糖素样肽-1
- The gene is called GRPR for dextrin(gastrin) releasing peptide receptor. 这种基因称之为GRPR－胃泌素释放肽受体。
- glucagons like peptide 胰高血糖素样肽
- The genge is called GRPR for gastrine releasing gastrin-releasing peptide receptor. 此基因被简称为GRPR，其全称是“胃泌素释放多肽受体”。
- The gene is called GRPR for Gastrine gastrin-releasing Releasing Petermy peptide Receptor. 有种基因被称作胃泌素释放肽受体，GRPR。
- The second part is the investigation of the oxidative folding and reductive unfolding pathway of amphioxus insulin like peptide (AILP). 第二部分研究了文昌鱼类胰岛素肽(AILP)的氧化折叠和还原解折叠途径。
- Aim: To investigate the effect of vasonatrin peptide (VNP) on the expression of C type natriuretic peptide receptor (NPR C) in hypoxic rat hearts. 目的 :探讨低氧对大鼠心脏钠尿肽C受体 (NPR C)表达的调节作用 ,以及血管钠肽 (VNP)对这一过程的影响。
- Gaus K, Hall EA. Short peptide receptor mimics for atherosclerosis risk assessment of LDL. Biosens Bioelectron 2003; 18: 151- 64. 胡大一、赵浓度、顼志敏：血脂及其调节与动脉粥样硬化的关系研究进展。中华老年心脑血管病杂志1999；1：66-9。
- derivate of glucagon like peptide-1 胰高血糖素样肽-1衍生物
- Pretreatment with calcitonin gene-related peptide receptor antagonis CGRP8-37 (30 nmol/kg) significantly reduced the action of ADM (3 nmol/kg) in the brain. 降钙素基因相关肽受体拮抗剂CGRP8-37(30nmol/kg)可明显减弱ADM的效应。
- The receptor blocker of glucagon is conceivab... 该文就高血糖素及其受体的研究进展作一论述。
- You can keep my book as long as you like. 我的书你要借多久都随你的便。
- I would like to have a word with you. 我想同你说句话。
- Research progresses in formyl peptide receptor 甲酰肽受体研究进展
- But until now most hydrophilic and macromolecular drugs like peptides, proteins and polysaccharides need to be injected due to low absorption at mucosal sites. 但是直到现在为止,大部分亲水性的大分子药物比如多肽、蛋白质以及多糖等,由于吸收太差,仍然只能采用注射的方式给药。
